KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Divestments (2020 - 2023)

Bio-Rad Laboratories (BIO) has disclosed Divestments for 3 consecutive years, with $2.5 million as the latest value for Q4 2023.

  • Quarterly Divestments rose 6150.0% to $2.5 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2023, up 6250.0% year-over-year, with the annual reading at $2.5 million for FY2023, 78.57% up from the prior year.
  • Divestments for Q4 2023 was $2.5 million at Bio-Rad Laboratories, up from $40000.0 in the prior quarter.
  • The five-year high for Divestments was $12.2 million in Q2 2020, with the low at $40000.0 in Q4 2022.
  • Average Divestments over 3 years is $4.9 million, with a median of $2.5 million recorded in 2023.
  • Peak annual rise in Divestments hit 6150.0% in 2023, while the deepest fall reached 6150.0% in 2023.
  • Over 3 years, Divestments stood at $12.2 million in 2020, then crashed by 99.67% to $40000.0 in 2022, then skyrocketed by 6150.0% to $2.5 million in 2023.
  • According to Business Quant data, Divestments over the past three periods came in at $2.5 million, $40000.0, and $12.2 million for Q4 2023, Q4 2022, and Q2 2020 respectively.